BRIGHTGENE
BrightGene Bio-medical technology Co.,Ltd., is a leading Chinese biopharmaceutical company in small molecules and nucleotide drugs areas. Advised by China-based venture capital fund Laurel Venture Capital, BrightGene invests in all stage therapeutics and innovations.
BRIGHTGENE
Industry:
Biopharma Biotechnology
Founded:
2001-01-01
Status:
Active
Total Funding:
550 M CNY
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Content Delivery Network Domain Not Resolving Mobile Non Scaleable Content DigiCert SSL GeoTrust SSL Baidu Analytics
Similar Organizations
Brickcells Technologies
Brickcells Technologies is a Biopharma company.
Enterin
Philadelphia-based biotechnology company .
Etern
Etern is a biopharma company.
Frontier Biotechnologies
Frontier Biotechnologies is a commercial-stage bio-pharmaceutical company.
Innovent Biologics
Innovent Biologics is a biopharmaceutical company that develops and manufactures monoclonal antibodies.
Minerva Neuroscience
Minerva Neurosciences is a clinical-stage biopharmaceutical company
Ocugen
Ocugen is a clinical stage biopharmaceutical company.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Highlight Capital
Highlight Capital investment in Venture Round - BrightGene
State Development & Investment Corporation
State Development & Investment Corporation investment in Venture Round - BrightGene
GF Qianhe Investment
GF Qianhe Investment investment in Venture Round - BrightGene
Sequoia Capital China
Sequoia Capital China investment in Venture Round - BrightGene
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2020-07-02 | Citryll | BrightGene investment in Series B - Citryll | 18.5 M EUR |
| 2019-07-03 | Citryll | BrightGene investment in Series A - Citryll | N/A |
| 2018-08-08 | DNALite Therapeutics | BrightGene investment in Seed Round - DNALite Therapeutics | 1.5 M USD |
More informations about "BrightGene"
About Us - BrightGene Health
BrightGene Health builds on decades of microbial research and development achievements from BrightGene Bio-Medical. Adhering to the principle of independent innovation, it places great …See details»
BrightGene
BrightGene Bio-Medical Technology Co., Ltd (stock code: 688166) is an innovative pharmaceutical enterprise participating in international competition. Relying on R&D drive, the …See details»
BrightGene - Crunchbase Investor Profile & Investments
BrightGene Bio-medical technology Co.,Ltd., is a leading Chinese biopharmaceutical company in small molecules and nucleotide drugs areas. Advised by China-based venture capital fund Laurel Venture Capital, …See details»
力行求是，勇于创新 - BrightGene
After years of continuous R&D and exploration,BrightGene has made breakthroughs in the fields of tumor targeted therapy and immunotherapy, as well as the treatment of fatty liver and diabetes. Many original new drugs have …See details»
China API and Intermediate, Formulation, Cosmetic …
BrightGene Bio-Medical Technology Co., Ltd is a high-end pharmaceutical company with high-barrier intermediates and APls as its core. Founded in 2001, the company has accumulated more than 20 years in the field of characteristic …See details»
BrightGene Bio-Medical Technology Company Description - Stock …
3 days ago Company profile for BrightGene Bio-Medical Technology Co., Ltd. (SHA: 688166) with a description, list of executives, contact details and other key facts.See details»
BrightGene
As the inventor of 269 patent applications (by the end of 2021), Dr. Yuan Jiandong, who led the research and development of several patent technologies of BrightGene, won the "China Patent Award" for "the synthesis method of …See details»
BrightGene - Investments, Portfolio & Company Exits - Crunchbase
Jan 29, 2024 BrightGene has made 4 investments. Their most recent investment was on Jan 29, 2024, when Aoli Biotechnology raised. How many investments has this organization made …See details»
BrightGene Company Profile - Office Locations, Competitors
Oct 29, 2024 BrightGene (博瑞生物医药) is a research-driven biopharmaceutical company that engages in the R&D and manufacturing of medicines. Its products include immuno-oncological …See details»
BrightGene (688166.SH)-Starquest Capital
BrightGene (688166.SH) Founded in October 2001, BrightGene Bio-Medical Technology Co.,Ltd. is a research-driven high-tech pharmaceutical company dedicated to the research and …See details»
BrightGene - VentureRadar
BrightGene Bio-Medical Technology Co., Ltd. specializes in the research, development, and manufacturing of innovative pharmaceutical products. The company is dedicated to advancing …See details»
BrightGene Bio-Medical Technology Co Ltd: Executives - GlobalData
The following section provides information on BrightGene Bio-Medical Technology Co Ltd’s senior management, executives, CEO and key decision makers and their roles in the organization. …See details»
BrightGene Bio-Medical Technology Company - PitchBook
BrightGene Bio-Medical Technology Company General Information Description. Brightgene Bio-medical Technology Co Ltd is a pharmaceutical company engaged in research, development …See details»
BrightGene
To provide patients with high-quality drugs, reduce their economic burden, solve their pain, bring hope for their lives, and benefit the societySee details»
BrightGene Bio-Medical Technology Co., Ltd - Sinodo Surgical …
BrightGene Bio-Medical Technology Co., Ltd. (stock code: 688166) is a global, innovative pharmaceutical company focused on R&D-driven emerging technology and the global market. …See details»
BrightGene - Funding, Financials, Valuation & Investors - Crunchbase
BrightGene is registered under the ticker SSE:688166 . Their stock opened with CN¥12.71 in its Nov 8, 2019 IPO. ... How much funding has this organization raised over time? Show . …See details»
BrightGene Bio-Medical Technology Co.,Ltd DMF, CEP, Written ...
BrightGene Bio-Medical Technology Co.,Ltd// BrightGene Bio-Medical Technology Co., Ltd. is a research driven biopharmaceutical company that engages in the R&D and manufacturing of …See details»
Introduction of BrightGene-Abby | PPT - SlideShare
Sep 22, 2016 5. Introduction-Milestone 2001 BrightGene Bio-Medical founded by Dr.Yuan 2006 BrightGene developed a non-infringing process of Entecavir 2010 BrightGene …See details»
BrightGene Bio-Medical Technology Co., Ltd. ESG Risk Rating
Brightgene Bio-medical Technology Co Ltd is a pharmaceutical company engaged in research, development and production of new drugs and high-end generic drugs. ... can be used to …See details»
Four manufacturers sign sublicence agreements with the …
Jun 22, 2023 Geneva – The Medicines Patent Pool (MPP) announced today that it has signed sublicence agreements with three India-based companies, Eugia, Hetero and Dr. Reddy’s …See details»